Pharma Digital Advertising Trends
The pharmaceutical industry is experiencing a significant shift towards digital advertising, with a reported 13% increase in digital media allocation. This trend indicates a structural reset in how pharma companies approach advertising in a regulated environment.
Digital Media Allocation Increase
Pharmaceutical companies are increasing their digital media budgets, reflecting a shift in advertising strategies.
Structural Reset in Advertising
The industry's move towards digital signifies a structural reset in how regulated advertising is approached.
Regulatory Adaptation
Pharma companies are adapting their advertising strategies to comply with regulatory standards while leveraging digital platforms.
Increased Competition in Digital Space
As more pharma companies invest in digital, competition for consumer attention is intensifying.
Focus on Consumer Engagement
The shift to digital is driven by a need for better consumer engagement and targeted advertising.
According to the dentsu-e4m Digital Advertising Report, pharma increased its digital allocation from 54% in 2024 to 67% in 2025
In 2025, the sector accounted for ₹4,933 crore in overall advertising spends. Out of this, ₹3,328 crore was directed specifically towards digital media